Ensysce Biosciences, Inc. (ENSC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.35M |
| Enterprise Value | 306.71B |
| P/E Ratio | -0.08 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.75 |
| Price/Book Ratio | -5.51 |
| Enterprise/Revenue | 1.4 |
| Enterprise/EBITDA | -0.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -8.11 |
| Operating Margin | -8.14 |
AD
Management Effectiveness
| Return On Assets | -5.44 |
| Return On Equity | -6.31 |
Income Statement
| Revenue | 5.07M |
| Revenue/Share | 0.21 |
| Gross Profit | -5.31M |
| EBITDA | -10.15M |
| Net Income | -10.18M |
| Diluted EPS | -3.98 |
Balance Sheet
| Total Cash | 745,482 |
| Total Cash/Share | 0.11 |
| Total Debt | 245,849 |
| Total Debt/Equity | -0.72 |
| Current Ratio | 0.71 |
| Book Value Per Share | -0.1 |
Price History
| 52-Week Change | -87.57 |
| 52-Week High | 2.75 |
| 52-Week Low | 0.23 |
| Moving Average 50 Days | 0.3 |
| Moving Average 200 Days | 0.98 |
Statistics
| Average Volume | 2.27M |
| Shares Outstanding | 9.28M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | December 06, 2024 |
AD
